Patent Assignment
Reel/Frame 060430/0942
Assignment of Assignor's Interest
Recorded: 2022-07-07
Pages: 18
Assignor
ORPHAZYME A/S
Executed: 2022-06-09
Assignee
KEMPHARM, INC.
1180 CELEBRATION BLVD., SUITE 103, CELEBRATION, FLORIDA, 34747
Covered Property
(1)
Use Of A Hydroximic Acid Halide Derivative In The Treatment Of Neurodegenerative Diseases
Application:
10/582,124 →
Publication:
US 2008/0039497
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 8, 2012
From: BIOREX KUTATO ES FEJLESZTO RT (VA); BRX RESEARCH AND DEVELOPMENT COMPANY LTD.
To: CYTRX CORPORATION
Reel/Frame 027671/0697 →
Assignment of Assignor's Interest
Feb 8, 2012
From: URBANICS, RUDOLF
To: CYTRX CORPORATION
Reel/Frame 027671/0717 →
Assignment of Assignor's Interest
Feb 8, 2012
From: CYTRX CORPORATION
To: ORPHAZYME APS
Reel/Frame 027671/0739 →
Assignment of Assignor's Interest
Feb 8, 2012
From: GREENSMITH, LINDA; BURNSTOCK, GEOFFREY
To: BIOREX RESEARCH AND DEVELOPMENT COMPANY RT (VA)
Reel/Frame 027675/0229 →
Assignment of Assignor's Interest
Jul 7, 2022
From: KEMPHARM, INC.
To: KEMPHARM DENMARK A/S
Reel/Frame 060430/0835 →
Change of Name
Oct 12, 2022
From: ORPHAZYME APS
To: ORPHAZYME A/S
Reel/Frame 061663/0293 →